PetIQ, Inc.
PetIQ, Inc. PETQ Peers
See (PETQ) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PETQ | $30.98 | -0.03% | 919.2M | 83.73 | $0.37 | N/A |
| ZTS | $166.25 | +2.26% | 74B | 29.79 | $5.58 | +1.15% |
| HLN | $11.24 | +0.90% | 50.7B | 26.76 | $0.42 | +1.51% |
| TAK | $14.69 | +0.82% | 46.2B | 63.87 | $0.23 | +4.04% |
| TEVA | $17.73 | +4.51% | 20.3B | -15.41 | -$1.15 | N/A |
| ITCI | $131.87 | N/A | 14B | -180.64 | -$0.73 | N/A |
| RDY | $14.74 | +2.50% | 12.3B | 18.66 | $0.79 | +0.67% |
| NBIX | $122.73 | +2.12% | 12.1B | 41.74 | $2.94 | N/A |
| CTLT | $63.48 | N/A | 11.5B | -27.84 | -$2.28 | N/A |
| VTRS | $8.61 | +3.86% | 10.1B | -2.71 | -$3.18 | +5.79% |
Stock Comparison
PETQ vs ZTS Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ZTS has a market cap of 74B. Regarding current trading prices, PETQ is priced at $30.98, while ZTS trades at $166.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ZTS's P/E ratio is 29.79. In terms of profitability, PETQ's ROE is +0.06%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, PETQ is less volatile compared to ZTS. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs HLN Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, HLN has a market cap of 50.7B. Regarding current trading prices, PETQ is priced at $30.98, while HLN trades at $11.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas HLN's P/E ratio is 26.76. In terms of profitability, PETQ's ROE is +0.06%, compared to HLN's ROE of +0.09%. Regarding short-term risk, PETQ is less volatile compared to HLN. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs TAK Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TAK has a market cap of 46.2B. Regarding current trading prices, PETQ is priced at $30.98, while TAK trades at $14.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TAK's P/E ratio is 63.87. In terms of profitability, PETQ's ROE is +0.06%, compared to TAK's ROE of +0.04%. Regarding short-term risk, PETQ is less volatile compared to TAK. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs TEVA Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TEVA has a market cap of 20.3B. Regarding current trading prices, PETQ is priced at $30.98, while TEVA trades at $17.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TEVA's P/E ratio is -15.41. In terms of profitability, PETQ's ROE is +0.06%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, PETQ is less volatile compared to TEVA. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ITCI Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, PETQ is priced at $30.98, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ITCI's P/E ratio is -180.64. In terms of profitability, PETQ's ROE is +0.06%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, PETQ is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for PETQ.
PETQ vs RDY Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, RDY has a market cap of 12.3B. Regarding current trading prices, PETQ is priced at $30.98, while RDY trades at $14.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas RDY's P/E ratio is 18.66. In terms of profitability, PETQ's ROE is +0.06%, compared to RDY's ROE of +0.18%. Regarding short-term risk, PETQ is less volatile compared to RDY. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs NBIX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, NBIX has a market cap of 12.1B. Regarding current trading prices, PETQ is priced at $30.98, while NBIX trades at $122.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas NBIX's P/E ratio is 41.74. In terms of profitability, PETQ's ROE is +0.06%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, PETQ is less volatile compared to NBIX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs CTLT Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, PETQ is priced at $30.98, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CTLT's P/E ratio is -27.84. In terms of profitability, PETQ's ROE is +0.06%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, PETQ is less volatile compared to CTLT. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs VTRS Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, VTRS has a market cap of 10.1B. Regarding current trading prices, PETQ is priced at $30.98, while VTRS trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas VTRS's P/E ratio is -2.71. In terms of profitability, PETQ's ROE is +0.06%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, PETQ is less volatile compared to VTRS. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs RGC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, RGC has a market cap of 6.6B. Regarding current trading prices, PETQ is priced at $30.98, while RGC trades at $505.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas RGC's P/E ratio is -1486.18. In terms of profitability, PETQ's ROE is +0.06%, compared to RGC's ROE of -0.25%. Regarding short-term risk, PETQ is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ELAN Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ELAN has a market cap of 6.5B. Regarding current trading prices, PETQ is priced at $30.98, while ELAN trades at $13.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ELAN's P/E ratio is 17.57. In terms of profitability, PETQ's ROE is +0.06%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, PETQ is less volatile compared to ELAN. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs LNTH Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, LNTH has a market cap of 5.2B. Regarding current trading prices, PETQ is priced at $30.98, while LNTH trades at $75.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas LNTH's P/E ratio is 21.58. In terms of profitability, PETQ's ROE is +0.06%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, PETQ is less volatile compared to LNTH. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs PRGO Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PRGO has a market cap of 3.8B. Regarding current trading prices, PETQ is priced at $30.98, while PRGO trades at $27.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PRGO's P/E ratio is -22.78. In terms of profitability, PETQ's ROE is +0.06%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, PETQ is less volatile compared to PRGO. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ALVOW Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ALVOW has a market cap of 3.4B. Regarding current trading prices, PETQ is priced at $30.98, while ALVOW trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ALVOW's P/E ratio is N/A. In terms of profitability, PETQ's ROE is +0.06%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, PETQ is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ALVO Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ALVO has a market cap of 3.4B. Regarding current trading prices, PETQ is priced at $30.98, while ALVO trades at $11.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ALVO's P/E ratio is 30.62. In terms of profitability, PETQ's ROE is +0.06%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, PETQ is less volatile compared to ALVO. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs AMRX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AMRX has a market cap of 3.4B. Regarding current trading prices, PETQ is priced at $30.98, while AMRX trades at $7.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AMRX's P/E ratio is -182.25. In terms of profitability, PETQ's ROE is +0.06%, compared to AMRX's ROE of -0.07%. Regarding short-term risk, PETQ is less volatile compared to AMRX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs BGM Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BGM has a market cap of 2.7B. Regarding current trading prices, PETQ is priced at $30.98, while BGM trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BGM's P/E ratio is -74.50. In terms of profitability, PETQ's ROE is +0.06%, compared to BGM's ROE of -0.03%. Regarding short-term risk, PETQ is less volatile compared to BGM. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs HCM Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, HCM has a market cap of 2.3B. Regarding current trading prices, PETQ is priced at $30.98, while HCM trades at $13.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas HCM's P/E ratio is 67.05. In terms of profitability, PETQ's ROE is +0.06%, compared to HCM's ROE of +0.05%. Regarding short-term risk, PETQ is less volatile compared to HCM. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs DCPH Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, PETQ is priced at $30.98, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas DCPH's P/E ratio is -11.58. In terms of profitability, PETQ's ROE is +0.06%, compared to DCPH's ROE of -0.52%. Regarding short-term risk, PETQ is less volatile compared to DCPH. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs EMBCV Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, PETQ is priced at $30.98, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EMBCV's P/E ratio is N/A. In terms of profitability, PETQ's ROE is +0.06%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, PETQ is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs SUPN Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SUPN has a market cap of 1.8B. Regarding current trading prices, PETQ is priced at $30.98, while SUPN trades at $32.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SUPN's P/E ratio is 29.37. In terms of profitability, PETQ's ROE is +0.06%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, PETQ is less volatile compared to SUPN. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs BHC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BHC has a market cap of 1.7B. Regarding current trading prices, PETQ is priced at $30.98, while BHC trades at $4.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BHC's P/E ratio is -38.25. In terms of profitability, PETQ's ROE is +0.06%, compared to BHC's ROE of +0.05%. Regarding short-term risk, PETQ is less volatile compared to BHC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs TARO Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, PETQ is priced at $30.98, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TARO's P/E ratio is 30.05. In terms of profitability, PETQ's ROE is +0.06%, compared to TARO's ROE of +0.03%. Regarding short-term risk, PETQ is less volatile compared to TARO. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs EVO Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EVO has a market cap of 1.5B. Regarding current trading prices, PETQ is priced at $30.98, while EVO trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EVO's P/E ratio is -6.48. In terms of profitability, PETQ's ROE is +0.06%, compared to EVO's ROE of -0.22%. Regarding short-term risk, PETQ is less volatile compared to EVO. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs INDV Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, INDV has a market cap of 1.5B. Regarding current trading prices, PETQ is priced at $30.98, while INDV trades at $11.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas INDV's P/E ratio is -236.50. In terms of profitability, PETQ's ROE is +0.06%, compared to INDV's ROE of -0.01%. Regarding short-term risk, PETQ is less volatile compared to INDV. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ANIP Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ANIP has a market cap of 1.3B. Regarding current trading prices, PETQ is priced at $30.98, while ANIP trades at $58.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ANIP's P/E ratio is -49.42. In terms of profitability, PETQ's ROE is +0.06%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, PETQ is less volatile compared to ANIP. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs AMPH Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AMPH has a market cap of 1.2B. Regarding current trading prices, PETQ is priced at $30.98, while AMPH trades at $25.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AMPH's P/E ratio is 9.25. In terms of profitability, PETQ's ROE is +0.06%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, PETQ is less volatile compared to AMPH. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs PCRX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PCRX has a market cap of 1.2B. Regarding current trading prices, PETQ is priced at $30.98, while PCRX trades at $25.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PCRX's P/E ratio is -11.53. In terms of profitability, PETQ's ROE is +0.06%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, PETQ is less volatile compared to PCRX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs DVAX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, DVAX has a market cap of 1.2B. Regarding current trading prices, PETQ is priced at $30.98, while DVAX trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas DVAX's P/E ratio is -19.56. In terms of profitability, PETQ's ROE is +0.06%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, PETQ is less volatile compared to DVAX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs PAHC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PAHC has a market cap of 991.9M. Regarding current trading prices, PETQ is priced at $30.98, while PAHC trades at $24.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PAHC's P/E ratio is 31.37. In terms of profitability, PETQ's ROE is +0.06%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, PETQ is less volatile compared to PAHC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs HROW Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, HROW has a market cap of 966.3M. Regarding current trading prices, PETQ is priced at $30.98, while HROW trades at $26.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas HROW's P/E ratio is -43.16. In terms of profitability, PETQ's ROE is +0.06%, compared to HROW's ROE of -0.36%. Regarding short-term risk, PETQ is less volatile compared to HROW. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs COLL Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, COLL has a market cap of 947.6M. Regarding current trading prices, PETQ is priced at $30.98, while COLL trades at $29.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas COLL's P/E ratio is 24.16. In terms of profitability, PETQ's ROE is +0.06%, compared to COLL's ROE of +0.19%. Regarding short-term risk, PETQ is less volatile compared to COLL. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs AVDL Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AVDL has a market cap of 876.5M. Regarding current trading prices, PETQ is priced at $30.98, while AVDL trades at $9.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AVDL's P/E ratio is -34.85. In terms of profitability, PETQ's ROE is +0.06%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, PETQ is less volatile compared to AVDL. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs CRON Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CRON has a market cap of 770.8M. Regarding current trading prices, PETQ is priced at $30.98, while CRON trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CRON's P/E ratio is 14.29. In terms of profitability, PETQ's ROE is +0.06%, compared to CRON's ROE of +0.05%. Regarding short-term risk, PETQ is less volatile compared to CRON. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs EMBC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EMBC has a market cap of 658.1M. Regarding current trading prices, PETQ is priced at $30.98, while EMBC trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EMBC's P/E ratio is 12.65. In terms of profitability, PETQ's ROE is +0.06%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, PETQ is less volatile compared to EMBC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs EOLS Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EOLS has a market cap of 632.5M. Regarding current trading prices, PETQ is priced at $30.98, while EOLS trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EOLS's P/E ratio is -11.02. In terms of profitability, PETQ's ROE is +0.06%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, PETQ is less volatile compared to EOLS. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs BDSI Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, PETQ is priced at $30.98, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BDSI's P/E ratio is 6.82. In terms of profitability, PETQ's ROE is +0.06%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, PETQ is less volatile compared to BDSI. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs TLRY Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TLRY has a market cap of 454.6M. Regarding current trading prices, PETQ is priced at $30.98, while TLRY trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TLRY's P/E ratio is -0.40. In terms of profitability, PETQ's ROE is +0.06%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, PETQ is less volatile compared to TLRY. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs SIGA Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SIGA has a market cap of 434.4M. Regarding current trading prices, PETQ is priced at $30.98, while SIGA trades at $6.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SIGA's P/E ratio is 9.07. In terms of profitability, PETQ's ROE is +0.06%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, PETQ is less volatile compared to SIGA. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ZYBT Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ZYBT has a market cap of 406.6M. Regarding current trading prices, PETQ is priced at $30.98, while ZYBT trades at $8.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ZYBT's P/E ratio is 143.00. In terms of profitability, PETQ's ROE is +0.06%, compared to ZYBT's ROE of +0.11%. Regarding short-term risk, PETQ is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs KMDA Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, KMDA has a market cap of 399.1M. Regarding current trading prices, PETQ is priced at $30.98, while KMDA trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas KMDA's P/E ratio is 24.79. In terms of profitability, PETQ's ROE is +0.06%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, PETQ is less volatile compared to KMDA. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ORGO Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ORGO has a market cap of 376.8M. Regarding current trading prices, PETQ is priced at $30.98, while ORGO trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ORGO's P/E ratio is -18.56. In terms of profitability, PETQ's ROE is +0.06%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, PETQ is less volatile compared to ORGO. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs EBS Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EBS has a market cap of 343.6M. Regarding current trading prices, PETQ is priced at $30.98, while EBS trades at $6.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EBS's P/E ratio is -2.45. In terms of profitability, PETQ's ROE is +0.06%, compared to EBS's ROE of -0.27%. Regarding short-term risk, PETQ is less volatile compared to EBS. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs SNDL Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SNDL has a market cap of 331.9M. Regarding current trading prices, PETQ is priced at $30.98, while SNDL trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SNDL's P/E ratio is -4.30. In terms of profitability, PETQ's ROE is +0.06%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, PETQ is less volatile compared to SNDL. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs TKNO Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TKNO has a market cap of 313.7M. Regarding current trading prices, PETQ is priced at $30.98, while TKNO trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TKNO's P/E ratio is -12.76. In terms of profitability, PETQ's ROE is +0.06%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, PETQ is less volatile compared to TKNO. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs CGC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CGC has a market cap of 306.1M. Regarding current trading prices, PETQ is priced at $30.98, while CGC trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CGC's P/E ratio is -0.47. In terms of profitability, PETQ's ROE is +0.06%, compared to CGC's ROE of -0.88%. Regarding short-term risk, PETQ is less volatile compared to CGC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ALIM Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, PETQ is priced at $30.98, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ALIM's P/E ratio is 5.28. In terms of profitability, PETQ's ROE is +0.06%, compared to ALIM's ROE of -0.34%. Regarding short-term risk, PETQ is less volatile compared to ALIM. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ACB Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ACB has a market cap of 300.5M. Regarding current trading prices, PETQ is priced at $30.98, while ACB trades at $5.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ACB's P/E ratio is 28.82. In terms of profitability, PETQ's ROE is +0.06%, compared to ACB's ROE of -0.06%. Regarding short-term risk, PETQ is less volatile compared to ACB. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs LNDC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, PETQ is priced at $30.98, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas LNDC's P/E ratio is -4.04. In terms of profitability, PETQ's ROE is +0.06%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, PETQ is less volatile compared to LNDC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs LFCR Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, LFCR has a market cap of 258.8M. Regarding current trading prices, PETQ is priced at $30.98, while LFCR trades at $6.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas LFCR's P/E ratio is -4.76. In terms of profitability, PETQ's ROE is +0.06%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, PETQ is less volatile compared to LFCR. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs AQST Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AQST has a market cap of 252.8M. Regarding current trading prices, PETQ is priced at $30.98, while AQST trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AQST's P/E ratio is -4.39. In terms of profitability, PETQ's ROE is +0.06%, compared to AQST's ROE of +1.07%. Regarding short-term risk, PETQ is less volatile compared to AQST. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs TYHT Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, PETQ is priced at $30.98, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TYHT's P/E ratio is -1.61. In terms of profitability, PETQ's ROE is +0.06%, compared to TYHT's ROE of -1.41%. Regarding short-term risk, PETQ is less volatile compared to TYHT. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs DERM Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, DERM has a market cap of 181.5M. Regarding current trading prices, PETQ is priced at $30.98, while DERM trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas DERM's P/E ratio is -21.05. In terms of profitability, PETQ's ROE is +0.06%, compared to DERM's ROE of -0.52%. Regarding short-term risk, PETQ is less volatile compared to DERM. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs OGI Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, OGI has a market cap of 178.7M. Regarding current trading prices, PETQ is priced at $30.98, while OGI trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas OGI's P/E ratio is 10.27. In terms of profitability, PETQ's ROE is +0.06%, compared to OGI's ROE of +0.05%. Regarding short-term risk, PETQ is less volatile compared to OGI. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs REPH Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, PETQ is priced at $30.98, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas REPH's P/E ratio is -8.04. In terms of profitability, PETQ's ROE is +0.06%, compared to REPH's ROE of -0.15%. Regarding short-term risk, PETQ is less volatile compared to REPH. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ESPR Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ESPR has a market cap of 162.5M. Regarding current trading prices, PETQ is priced at $30.98, while ESPR trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ESPR's P/E ratio is -0.96. In terms of profitability, PETQ's ROE is +0.06%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, PETQ is less volatile compared to ESPR. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs BIOA Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BIOA has a market cap of 141.2M. Regarding current trading prices, PETQ is priced at $30.98, while BIOA trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BIOA's P/E ratio is -1.99. In terms of profitability, PETQ's ROE is +0.06%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, PETQ is less volatile compared to BIOA. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs THTX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, THTX has a market cap of 119.3M. Regarding current trading prices, PETQ is priced at $30.98, while THTX trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas THTX's P/E ratio is -37.07. In terms of profitability, PETQ's ROE is +0.06%, compared to THTX's ROE of +0.16%. Regarding short-term risk, PETQ is less volatile compared to THTX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs SCTL Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, PETQ is priced at $30.98, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SCTL's P/E ratio is -7.86. In terms of profitability, PETQ's ROE is +0.06%, compared to SCTL's ROE of -0.15%. Regarding short-term risk, PETQ is less volatile compared to SCTL. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs PROC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PROC has a market cap of 114M. Regarding current trading prices, PETQ is priced at $30.98, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PROC's P/E ratio is 1.53. In terms of profitability, PETQ's ROE is +0.06%, compared to PROC's ROE of -2.22%. Regarding short-term risk, PETQ is less volatile compared to PROC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs IRWD Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, IRWD has a market cap of 100.7M. Regarding current trading prices, PETQ is priced at $30.98, while IRWD trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas IRWD's P/E ratio is -3.28. In terms of profitability, PETQ's ROE is +0.06%, compared to IRWD's ROE of +0.10%. Regarding short-term risk, PETQ is less volatile compared to IRWD. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs OPTN Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, PETQ is priced at $30.98, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas OPTN's P/E ratio is -4.42. In terms of profitability, PETQ's ROE is +0.06%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, PETQ is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for PETQ.
PETQ vs CRDL Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CRDL has a market cap of 95.8M. Regarding current trading prices, PETQ is priced at $30.98, while CRDL trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CRDL's P/E ratio is -3.41. In terms of profitability, PETQ's ROE is +0.06%, compared to CRDL's ROE of -2.08%. Regarding short-term risk, PETQ is less volatile compared to CRDL. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ZOM Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, PETQ is priced at $30.98, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ZOM's P/E ratio is -1.62. In terms of profitability, PETQ's ROE is +0.06%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, PETQ is less volatile compared to ZOM. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs GRVI Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, PETQ is priced at $30.98, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas GRVI's P/E ratio is 26.05. In terms of profitability, PETQ's ROE is +0.06%, compared to GRVI's ROE of -5.25%. Regarding short-term risk, PETQ is less volatile compared to GRVI. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs CPIX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CPIX has a market cap of 80.6M. Regarding current trading prices, PETQ is priced at $30.98, while CPIX trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CPIX's P/E ratio is -22.46. In terms of profitability, PETQ's ROE is +0.06%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, PETQ is less volatile compared to CPIX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs INCR Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, INCR has a market cap of 73.5M. Regarding current trading prices, PETQ is priced at $30.98, while INCR trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas INCR's P/E ratio is -3.71. In terms of profitability, PETQ's ROE is +0.06%, compared to INCR's ROE of -0.07%. Regarding short-term risk, PETQ is less volatile compared to INCR. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ZYNE Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, PETQ is priced at $30.98, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, PETQ's ROE is +0.06%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, PETQ is less volatile compared to ZYNE. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs SSIC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, PETQ is priced at $30.98, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SSIC's P/E ratio is 11.93. In terms of profitability, PETQ's ROE is +0.06%, compared to SSIC's ROE of +0.03%. Regarding short-term risk, PETQ is less volatile compared to SSIC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ASRT Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ASRT has a market cap of 65M. Regarding current trading prices, PETQ is priced at $30.98, while ASRT trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ASRT's P/E ratio is -2.12. In terms of profitability, PETQ's ROE is +0.06%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, PETQ is less volatile compared to ASRT. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs VLNS Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, PETQ is priced at $30.98, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas VLNS's P/E ratio is -1.03. In terms of profitability, PETQ's ROE is +0.06%, compared to VLNS's ROE of N/A. Regarding short-term risk, PETQ is less volatile compared to VLNS. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs JUPW Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, PETQ is priced at $30.98, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas JUPW's P/E ratio is -2.41. In terms of profitability, PETQ's ROE is +0.06%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, PETQ is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs SXTC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SXTC has a market cap of 39.3M. Regarding current trading prices, PETQ is priced at $30.98, while SXTC trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SXTC's P/E ratio is 0.01. In terms of profitability, PETQ's ROE is +0.06%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, PETQ is less volatile compared to SXTC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs QLI Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, PETQ is priced at $30.98, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas QLI's P/E ratio is -4.92. In terms of profitability, PETQ's ROE is +0.06%, compared to QLI's ROE of -0.16%. Regarding short-term risk, PETQ is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for PETQ.
PETQ vs QNTM Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, QNTM has a market cap of 33.6M. Regarding current trading prices, PETQ is priced at $30.98, while QNTM trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas QNTM's P/E ratio is -0.88. In terms of profitability, PETQ's ROE is +0.06%, compared to QNTM's ROE of -1.88%. Regarding short-term risk, PETQ is less volatile compared to QNTM. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs RMTI Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, RMTI has a market cap of 32.9M. Regarding current trading prices, PETQ is priced at $30.98, while RMTI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas RMTI's P/E ratio is -96.27. In terms of profitability, PETQ's ROE is +0.06%, compared to RMTI's ROE of -0.01%. Regarding short-term risk, PETQ is less volatile compared to RMTI. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs HEXO Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, PETQ is priced at $30.98, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas HEXO's P/E ratio is -0.26. In terms of profitability, PETQ's ROE is +0.06%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, PETQ is less volatile compared to HEXO. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs SCYX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SCYX has a market cap of 28.5M. Regarding current trading prices, PETQ is priced at $30.98, while SCYX trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SCYX's P/E ratio is -1.30. In terms of profitability, PETQ's ROE is +0.06%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, PETQ is less volatile compared to SCYX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs KALA Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, KALA has a market cap of 26.2M. Regarding current trading prices, PETQ is priced at $30.98, while KALA trades at $4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas KALA's P/E ratio is -0.55. In terms of profitability, PETQ's ROE is +0.06%, compared to KALA's ROE of -3.69%. Regarding short-term risk, PETQ is less volatile compared to KALA. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs EGRX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EGRX has a market cap of 25.9M. Regarding current trading prices, PETQ is priced at $30.98, while EGRX trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EGRX's P/E ratio is 2.35. In terms of profitability, PETQ's ROE is +0.06%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, PETQ is more volatile compared to EGRX. This indicates potentially higher risk in terms of short-term price fluctuations for PETQ.
PETQ vs CYTH Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, PETQ is priced at $30.98, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CYTH's P/E ratio is -0.80. In terms of profitability, PETQ's ROE is +0.06%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, PETQ is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for PETQ.
PETQ vs IXHL Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, IXHL has a market cap of 19.3M. Regarding current trading prices, PETQ is priced at $30.98, while IXHL trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas IXHL's P/E ratio is -0.22. In terms of profitability, PETQ's ROE is +0.06%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, PETQ is less volatile compared to IXHL. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs TXMD Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TXMD has a market cap of 17.2M. Regarding current trading prices, PETQ is priced at $30.98, while TXMD trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TXMD's P/E ratio is -7.84. In terms of profitability, PETQ's ROE is +0.06%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, PETQ is less volatile compared to TXMD. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs GELS Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, GELS has a market cap of 17M. Regarding current trading prices, PETQ is priced at $30.98, while GELS trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas GELS's P/E ratio is -7.50. In terms of profitability, PETQ's ROE is +0.06%, compared to GELS's ROE of -0.21%. Regarding short-term risk, PETQ is less volatile compared to GELS. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs DRRX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, DRRX has a market cap of 15.5M. Regarding current trading prices, PETQ is priced at $30.98, while DRRX trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas DRRX's P/E ratio is -1.04. In terms of profitability, PETQ's ROE is +0.06%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, PETQ is less volatile compared to DRRX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs FLGC Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, FLGC has a market cap of 15.4M. Regarding current trading prices, PETQ is priced at $30.98, while FLGC trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas FLGC's P/E ratio is -0.71. In terms of profitability, PETQ's ROE is +0.06%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, PETQ is less volatile compared to FLGC. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs SISI Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SISI has a market cap of 15.3M. Regarding current trading prices, PETQ is priced at $30.98, while SISI trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SISI's P/E ratio is N/A. In terms of profitability, PETQ's ROE is +0.06%, compared to SISI's ROE of -1.41%. Regarding short-term risk, PETQ is less volatile compared to SISI. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs PRPH Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PRPH has a market cap of 14.9M. Regarding current trading prices, PETQ is priced at $30.98, while PRPH trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PRPH's P/E ratio is -0.16. In terms of profitability, PETQ's ROE is +0.06%, compared to PRPH's ROE of -1.59%. Regarding short-term risk, PETQ is less volatile compared to PRPH. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ACRX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, PETQ is priced at $30.98, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ACRX's P/E ratio is -0.31. In terms of profitability, PETQ's ROE is +0.06%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, PETQ is less volatile compared to ACRX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs COSM Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, COSM has a market cap of 13.4M. Regarding current trading prices, PETQ is priced at $30.98, while COSM trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas COSM's P/E ratio is -0.43. In terms of profitability, PETQ's ROE is +0.06%, compared to COSM's ROE of -0.51%. Regarding short-term risk, PETQ is less volatile compared to COSM. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs AYTU Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AYTU has a market cap of 12.2M. Regarding current trading prices, PETQ is priced at $30.98, while AYTU trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AYTU's P/E ratio is -1.33. In terms of profitability, PETQ's ROE is +0.06%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, PETQ is less volatile compared to AYTU. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs AGRX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, PETQ is priced at $30.98, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AGRX's P/E ratio is -0.89. In terms of profitability, PETQ's ROE is +0.06%, compared to AGRX's ROE of +1.04%. Regarding short-term risk, PETQ is less volatile compared to AGRX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs TLPH Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TLPH has a market cap of 10.3M. Regarding current trading prices, PETQ is priced at $30.98, while TLPH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TLPH's P/E ratio is -1.14. In terms of profitability, PETQ's ROE is +0.06%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, PETQ is less volatile compared to TLPH. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs YCBD Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, YCBD has a market cap of 8.8M. Regarding current trading prices, PETQ is priced at $30.98, while YCBD trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas YCBD's P/E ratio is 0.01. In terms of profitability, PETQ's ROE is +0.06%, compared to YCBD's ROE of -8.81%. Regarding short-term risk, PETQ is less volatile compared to YCBD. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs BFRIW Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BFRIW has a market cap of 8.3M. Regarding current trading prices, PETQ is priced at $30.98, while BFRIW trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BFRIW's P/E ratio is -0.10. In terms of profitability, PETQ's ROE is +0.06%, compared to BFRIW's ROE of -2.16%. Regarding short-term risk, PETQ is less volatile compared to BFRIW. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs NLTX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, PETQ is priced at $30.98, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas NLTX's P/E ratio is -0.28. In terms of profitability, PETQ's ROE is +0.06%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, PETQ is less volatile compared to NLTX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs LCI Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, PETQ is priced at $30.98, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas LCI's P/E ratio is -0.04. In terms of profitability, PETQ's ROE is +0.06%, compared to LCI's ROE of +1.66%. Regarding short-term risk, PETQ is less volatile compared to LCI. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs BGXX Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BGXX has a market cap of 7.3M. Regarding current trading prices, PETQ is priced at $30.98, while BGXX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BGXX's P/E ratio is -0.76. In terms of profitability, PETQ's ROE is +0.06%, compared to BGXX's ROE of -0.88%. Regarding short-term risk, PETQ is less volatile compared to BGXX. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.
PETQ vs ADMP Comparison
PETQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, PETQ is priced at $30.98, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ADMP's P/E ratio is -0.08. In terms of profitability, PETQ's ROE is +0.06%, compared to ADMP's ROE of +0.00%. Regarding short-term risk, PETQ is less volatile compared to ADMP. This indicates potentially lower risk in terms of short-term price fluctuations for PETQ.